Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non Operating Income: 2014-2025

Historic Other Non Operating Income for KalVista Pharmaceuticals (KALV) over the last 6 years, with Apr 2025 value amounting to $2.1 million.

  • KalVista Pharmaceuticals' Other Non Operating Income fell 12.87% to $2.1 million in Q2 2025 from the same period last year, while for Apr 2025 it was $8.4 million, marking a year-over-year decrease of 17.07%. This contributed to the annual value of $4.8 million for FY2025, which is 50.73% down from last year.
  • KalVista Pharmaceuticals' Other Non Operating Income amounted to $2.1 million in Q2 2025, which was up 35.31% from $1.6 million recorded in Q3 2024.
  • KalVista Pharmaceuticals' 5-year Other Non Operating Income high stood at $2.4 million for Q2 2024, and its period low was $1.6 million during Q3 2024.
  • Its 2-year average for Other Non Operating Income is $2.1 million, with a median of $2.2 million in 2024.
  • Data for KalVista Pharmaceuticals' Other Non Operating Income shows a maximum YoY dropped of 12.87% (in 2025) over the last 5 years.
  • Over the past 2 years, KalVista Pharmaceuticals' Other Non Operating Income (Quarterly) stood at $1.6 million in 2024, then declined by 12.87% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q2 2025, $1.6 million for Q3 2024, and $2.4 million during Q2 2024.